Indian Journal of Critical Care Medicine

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 28 , ISSUE 7 ( July, 2024 ) > List of Articles


Interleukin-6 in Sepsis—Promising but Yet to Be Proven

Saswati Sinha

Keywords : Acute physiology and chronic health evaluation-II, APACHE II score, Biomarkers, ICU prognostic models, Interleukin-6, Predictive model, Sepsis, Sepsis and ICU, Sequential organ failure assessment

Citation Information : Sinha S. Interleukin-6 in Sepsis—Promising but Yet to Be Proven. Indian J Crit Care Med 2024; 28 (7):629-631.

DOI: 10.5005/jp-journals-10071-24758

License: CC BY-NC 4.0

Published Online: 29-06-2024

Copyright Statement:  Copyright © 2024; The Author(s).


PDF Share
  1. Schulte W, Bernhagen J, Bucala R. Cytokines in sepsis: Potent immunoregulators and potential therapeutic targets–An updated view. Mediators Inflamm 2013;2013:165974. DOI: 10.1155/2013/165974.
  2. Castellanos-Ortega A, Suberviola B, García-Astudillo LA, Holanda MS, Ortiz F, Llorca J, et al. Impact of the surviving sepsis campaign protocols on hospital length of stay and mortality in septic shock patients: Results of a three-year follow-up quasi-experimental study. Crit Care Med 2010;38(4):1036–1043. DOI: 10.1097/CCM.0b013e3181d455b6.
  3. Pierrakos C, Velissaris D, Bisdorff M, Marshall JC, Vincent JL. Biomarkers of sepsis: Time for a reappraisal. Crit Care 2020;24(1):287. DOI: 10.1186/s13054-020-02993-5.
  4. Lukaszewicz M, Mroczko B, Szmitkowski M. Clinical significance of interleukin-6 (IL-6) as a prognostic factor of cancer disease. Pol Arch Med Wewn 2007;117(5–6):247–251. Polish. PMID: 18030875.
  5. Patterson CC, Smith AE, Yarnell JW, Rumley A, Ben-Shlomo Y, Lowe GD. The associations of interleukin-6 (IL-6) and downstream inflammatory markers with risk of cardiovascular disease: The Caerphilly study. Atherosclerosis 2010;209(2):551–557. DOI: 10.1016/j.atherosclerosis.2009.09.030.
  6. Ishihara K, Hirano T. IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev 2002;13(4-5):357–368. DOI: 10.1016/s1359-6101(02)00027-8.
  7. Henning DJ, Hall MK, Watsjold BK, Bhatraju PK, Kosamo S, Shapiro NI, et al. Interleukin-6 improves infection identification when added to physician judgment during evaluation of potentially septic patients. Am J Emerg Med 2020;38(5):947–952. DOI: 10.1016/j.ajem.2019.158361.
  8. Dimoula A, Pradier O, Kassengera Z, Dalcomune D, Turkan H, Vincent JL. Serial determinations of neutrophil CD64 expression for the diagnosis and monitoring of sepsis in critically ill patients. Clin Infect Dis 2014;58(6):820–829. DOI: 10.1093/cid/cit936.
  9. Chaaban H, Singh K, Huang J, Siryaporn E, Lim YP, Padbury JF. The role of inter-alpha inhibitor proteins in the diagnosis of neonatal sepsis. J Pediatr 2009;154(4):620–622.e1. DOI: 10.1016/j.jpeds.2008.10.008.
  10. Reddy PRV, Cherukuri M, Eshwara VK, Kudru CU, Krishnananda Prabhu RV. Diagnostic potential of serum interleukin-6 in predicting bacteremia in adult patients with sepsis: A prospective observational study. Indian J Crit Care Med 2024;28(7):637–644.
  11. Molano Franco D, Arevalo-Rodriguez I, Roqué I Figuls M, Montero Oleas NG, Nuvials X, Zamora J. Plasma interleukin-6 concentration for the diagnosis of sepsis in critically ill adults. Cochrane Database Syst Rev 2019;4(4):CD011811. DOI: 10.1002/14651858.CD011811.pub2.
  12. Yu B, Chen M, Zhang Y, Cao Y, Yang J, Wei B, et al. Diagnostic and prognostic value of interleukin-6 in emergency department sepsis patients. Infect Drug Resist 2022; 2022(15):5557–5566. DOI: 10.2147/IDR.S384351.
  13. Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau GE, et al. Geneva Sepsis Network. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001;164(3):396–402. DOI: 10.1164/ajrccm.164.3.2009052.
  14. Weidhase L, Wellhöfer D, Schulze G, Kaiser T, Drogies T, Wurst U, et al. Is interleukin-6 a better predictor of successful antibiotic therapy than procalcitonin and C-reactive protein? A single center study in critically ill adults. BMC Infect Dis 2019;19(1):150. DOI: 10.1186/s12879-019-3800-2.
  15. Kellum JA, Kong L, Fink MP, Weissfeld LA, Yealy DM, Pinsky MR, et al. Understanding the inflammatory cytokine response in pneumonia and sepsis: Results of the genetic and inflammatory markers of sepsis (GenIMS) study. Arch Intern Med 2007;167(15):1655–1663. DOI: 10.1001/archinte.167.15.1655.
  16. Akkaya O, Mutlu N, Köylü R, Akıllı NB, Köylü Ö, Eryılmaz M. Assessment of the correlations between interleukin-6 and 10 levels and mortality in patients with sepsis. Ann Med Res 2023;30(1):38–44. DOI: 10.5455/annalsmedres.2022.08.234.
  17. Miguel-Bayarri V, Casanoves-Laparra EB, Pallás-Beneyto L, Sancho-Chinesta S, Martín-Osorio LF, Tormo-Calandín C, et al. Prognostic value of the biomarkers procalcitonin, interleukin-6 and C-reactive protein in severe sepsis. Med Intensiva 2012;36(8):556–562. DOI: 10.1016/j.medin.2012.01.014.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.